We have located links that may give you full text access.
Synthesis, characterization, and utilization of a diallylmethylamine-based cyclopolymer for corrosion mitigation in simulated acidizing environment.
A novel random copolymer 4, containing diallylmethylamine and N1 ,N1 -diallyl-N1 -methyl-N6 ,N6 ,N6 -tripropylhexane-1,6-diammonium dibromide units in a 1:1 ratio (polymer 4) was synthesized via Butler's cyclopolymerization technique. Characterization was accomplished by 1 H NMR, elemental analysis, and Fourier-transform infrared spectroscopy (FTIR). Polymer 4 was tested as corrosion inhibitor for low carbon steel in 15% HCl solution via gravimetric and electrochemical approaches. The analysis of the metal specimen surfaces was done using scanning electron microscope (SEM), atomic force microscopy (AFM), energy dispersive X-ray spectroscopy (EDAX), and X-ray photoelectron spectroscopy (XPS) methods. Polymer 4 is inhibitor for the substrate particularly at elevated temperatures. Corrosion mitigation is by chemisorption mechanism and can be best described with the Langmuir and El-Awady et al. kinetic-thermodynamic adsorption isotherms. Polymer 4 corrosion mitigation capacity can be improved by the addition of a minute amount of I- ions. Inhibition efficiency of 92.99% has been achieved with 500 ppm polymer 4 + 1 mM KI mixture at 25 °C. Surface analysis results support the claim of adsorption of additive molecules on steel surface. From XPS results, corrosion products on steel surface exposed to the free acid solution are mixtures of chlorides, carbonates, oxides, and hydroxides. In polymer 4 + KI system, polymer 4 molecules are adsorbed on triiodide and pentaiodide ions layer. The improved corrosion inhibition of polymer 4 by I- ions is synergistic in nature according to calculated synergism parameter. Polymer 4 is a promising corrosion inhibitor for oil well acidizing purpose.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app